GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1294-1296

  Orvieto, Raoul ^a,b   Meltzer, Simion ^a   Rabinson, Jacob ^a   Zohav, Efraim ^a,b   Anteby, Eyal Y ^a,b   Nahum, Ravit ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 41749106070     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.022     Document Type: Article

References (19)

1. Al-Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17 (2002) 874-885
2. Al-Inany H., Abou-Setta A.M., and Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 14 (2007) 640-649
3. Ludwig M., Katalinic A., and Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet 265 (2001) 175-182
4. Fauser B.C., and Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?. Fertil Steril 83 (2005) 1607-1611
5. Griesinger G., Felberbaum R., and Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German National IVF Registry. Hum Reprod 20 (2005) 2373-2375
6. Orvieto R., Rabinson J., Meltzer S., Homburg R., Anteby E., and Zohav E. GnRH agonist versus GnRH antagonist in ovarian stimulation: is the emperor naked?. Clin Exp Obstet Gynecol 33 (2006) 197-199
7. Simon C., Oberye J., Bellver J., Vidal C., Bosch E., Horcajadas J.A., et al. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod 20 (2005) 3318-3327
8. Martinez-Conejero J.A., Simon C., Pellicer A., and Horcajadas J.A. Is ovarian stimulation detrimental to the endometrium?. Reprod Biomed Online 15 (2007) 45-50
9. Ruan H.C., Zhu X.M., Luo Q., Liu A.X., Qian Y.L., Zhou C.Y., et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod 21 (2006) 2521-2529
10. Ziebe S., Lundin K., Janssens R., Helmgaard L., Arce J.C., and MERIT Group. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod 22 (2007) 2404-2413
11. Rabinson J, Meltcer S, Zohav E, Gemer O, Anteby EY, Orvieto R. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in-vitro fertilization outcome. Fertil Steril. In press.
12. 2/oocyte ratios on the outcome of controlled ovarian stimulation for in-vitro fertilization. Gynecol Endocrinol 23 (2007) 72-75
13. Orvieto R, Rabinson J, Meltcer S, Gemer O, Anteby EY, Zohav E. Does physicians' experience influence IVF success in patients undergoing controlled ovarian stimulation with GnRH-antagonists? Fertil Steril. In press.
14. Hernandez E.R. Embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 15 (2000) 1211-1216
15. Gartner B., Moreno C., Marinaro A., Remohi J., Simon C., and Pellicer A. Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilisation cycle. Hum Reprod 12 (1997) 2557-2559
16. Seshagiri P.B., Terasawa E., and Hern J.P. Secretion of gonadotrophin-releasing hormone by peri-implantation embryos of the rhesus monkey: comparison with the secretion of chorionic gonadotrophin. Hum Reprod 9 (1994) 1300-1307
17. Fujii S., Sato S., Fukui A., Kimura H., Kasai G., and Saito Y. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF. Hum Reprod 16 (2001) 1671-1675
18. Orvieto R., Rabinson J., Meltzer S., Zohav E., Anteby E., and Homburg R. Substituting hCG with GnRH agonist to trigger final follicular maturation-a retrospective comparison of three different ovarian stimulation protocols. Reprod Biomed Online 13 (2006) 198-201
19. Tarlatzis B.C., Zepiridis L., Grimbizis G., and Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9 (2003) 61-76